These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
91 related items for PubMed ID: 6543401
1. [Effect of various doses of naloxone on circulating corticosterone levels in the rat]. Montilla P, Torrecillas F, Varo A, Muñoz MC. Rev Esp Fisiol; 1984 Dec; 40(4):401-4. PubMed ID: 6543401 [Abstract] [Full Text] [Related]
2. [Effect of oxytocin and naloxone on the plasma levels of corticosterone in the rat]. Montilla P, Muñoz JL, Ríos JE, Muñoz MC. Rev Esp Fisiol; 1989 Dec; 45(4):319-22. PubMed ID: 2631154 [Abstract] [Full Text] [Related]
3. Inhibition of neural and neuroendocrine activity by alpha-interferon: neuroendocrine, electrophysiological, and biochemical studies in the rat. Saphier D, Roerig SC, Ito C, Vlasak WR, Farrar GE, Broyles JE, Welch JE. Brain Behav Immun; 1994 Mar; 8(1):37-56. PubMed ID: 8003770 [Abstract] [Full Text] [Related]
10. Naloxone does not reverse the inhibitory effect of morphine on luteinizing hormone secretion in prepubescent male rats. Cicero TJ, Nock B, O'Connor L. J Pharmacol Exp Ther; 1993 Jan; 264(1):47-53. PubMed ID: 8380870 [Abstract] [Full Text] [Related]
12. The nociceptin/orphanin FQ antagonist UFP-101 differentially modulates the glucocorticoid response to restraint stress in rats during the peak and nadir phases of the hypothalamo-pituitary-adrenal axis circadian rhythm. Leggett JD, Jessop DS, Fulford AJ. Neuroscience; 2007 Jul 13; 147(3):757-64. PubMed ID: 17574767 [Abstract] [Full Text] [Related]
13. Effect of naloxone on central adrenergic stimulation of corticosterone secretion. Gadek-Michalska A, Turoń M, Bugajski J. Folia Med Cracov; 1997 Jul 13; 38(3-4):37-45. PubMed ID: 10481380 [Abstract] [Full Text] [Related]
14. Influence of cyclooxygenase inhibitors on the central histaminergic stimulations of hypothalamic - pituitary - adrenal axis. Bugajski AJ, Thor P, Głód R, Gadek-Michalska A, Bugajski J. J Physiol Pharmacol; 2003 Dec 13; 54(4):643-52. PubMed ID: 14726617 [Abstract] [Full Text] [Related]
16. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro. Calogero AE, Scaccianoce S, Burrello N, Nicolai R, Muscolo LA, Kling MA, Angelucci L, D'Agata R. J Neuroendocrinol; 1996 Aug 13; 8(8):579-85. PubMed ID: 8866244 [Abstract] [Full Text] [Related]
17. Imidazoline2 (I2) receptor- and alpha2-adrenoceptor-mediated modulation of hypothalamic-pituitary-adrenal axis activity in control and acute restraint stressed rats. Finn DP, Hudson AL, Kinoshita H, Coventry TL, Jessop DS, Nutt DJ, Harbuz MS. J Psychopharmacol; 2004 Mar 13; 18(1):47-53. PubMed ID: 15107184 [Abstract] [Full Text] [Related]
18. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. Swain MG, Patchev V, Vergalla J, Chrousos G, Jones EA. J Clin Invest; 1993 May 13; 91(5):1903-8. PubMed ID: 8387536 [Abstract] [Full Text] [Related]